MD Anderson Cancer Network — Houston, Texas

MD Anderson Cancer Network is a clinical research site located in Houston, Texas, United States 77030.

Crixeo Health Trust Score: 46/100 (POOR). This profile has not yet been claimed by the site owner.

MD Anderson Cancer Network has participated in 1 clinical trials.

Therapeutic areas: Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcinoma of the Pancreas, Stage IV Pancreatic Cancer.

Sponsors: National Cancer Institute (NCI).

Sponsor Feasibility Report

Trust Score: 46/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for MD Anderson Cancer Network?

MD Anderson Cancer Network has a Crixeo Trust Score of 46/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has MD Anderson Cancer Network conducted?

MD Anderson Cancer Network has 1 clinical trials on record. Their work covers Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcinoma of the Pancreas, Stage IV Pancreatic Cancer.

Is MD Anderson Cancer Network accredited by Crixeo Health?

MD Anderson Cancer Network has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about MD Anderson Cancer Network?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.